KESSEL MEDintim GmbH, WCG Cares and Population Services International
Announce Launch of Caya™ Diaphragm and Caya™ Gel in Niger
12 July 2019
FRANKFURT and SAN DIEGO and WASHINGTON – KESSEL MEDintim, WCG Cares (WCG) and Population Services International (PSI) announced the launch of the Caya™ Diaphragm and Caya™ Gel in Niger.
The introduction of the Caya™ Diaphragm and Caya™ Gel in Niger is supported by the Expanding Effective Contraceptive Options (EECO) project, which is funded by the United States Agency for International Development (USAID). The EECO project, led by WCG and implemented in partnership with PSI, was designed to support the introduction of new and improved contraceptive methods that address method-related reasons for non-use of family planning to better meet the reproductive health needs of women and girls worldwide. The launch of the Caya™ Diaphragm and Caya™ Gel, a non-hormonal, discreet and reusable barrier method, supports WCG’s and PSI’s joint efforts to expand access to an array of contraceptive options. PSI will market and distribute the Caya™ Diaphragm and Caya™ Gel in Niger’s capital of Niamey, training community health workers and healthcare providers to offer the method to women alongside other options within the context of informed choice.
Niger has one of the world’s highest fertility rates, with women having more than seven children in their lifetime on average, in part due to extremely low use of contraception. Yet the Government of Niger is committed to increasing contraceptive use not only as a means to reduce maternal and child morbidity and mortality but also to boost economic development. KESSEL MEDintim, WCG and PSI are dedicated to increasing access to a full range of contraceptive options in Niger, including those that respond to preferences for non-hormonal, on-demand methods like the Caya™ Diaphragm and Caya™ Gel. Unlike previous iterations of the diaphragm, the Caya™ Diaphragm is “one size fits most,” eliminating the need for a provider fitting in countries like Niger with shortages of trained healthcare providers.
“Our market research shows that women and men desire more contraceptive options that are within their control and have no side effects,” said Moumouni Boubacar, EECO Project Manager at PSI Niger. “The Caya™ Diaphragm puts power in the hands of the couple, which can decide when they want to start and stop contraception with no need to see a provider in a busy health care center.”
“We are excited to see the response of women and providers to the Caya diaphragm—especially to see if Caya can help meet the needs of women who do not want to use other types of contraceptives,” said Martin Kessel, CEO of KESSEL MEDintim. “We know women in other countries have easily learned to use Caya and like this new method, so in Niger this will be explored. Since diaphragms have not been available or promoted in decades, we are not just testing acceptability of another variation of a contraceptive, we are introducing a new type of method to women and their partners, and even to family planning providers, who have not had an option like this before.”
“Women’s contraceptive needs change throughout their lives and they need methods that align with their unique circumstances,” said Shannon Bledsoe, WCG Executive Director. “The introduction of this on-demand, non-hormonal method gives women in Niger one more contraceptive choice.”
About KESSEL MEDintim
KESSEL Medintim is a manufacturer of medical devices, specialized in contraceptives and health care products for men and women. The company is based in Frankfurt am Main and supplies more than 40 countries through a network of local partners. KESSEL Medintim is ISO CE 13485 certified for research, development and manufacturing with extended MDSAP approval for the USA (FDA), Canadian Health and Australia (TGA). With more than 30 years of experience, KESSEL Medintim is highly innovative with new technologies and uses advanced materials.
About WCG Cares
WCG is an international non-profit organization committed to empowering, educating and enabling women and girls to make informed choices and access critical reproductive health products and services. WCG’s credentials in product introduction have made it a preferred partner of organizations looking to move products from laboratories and manufacturing plants to the women who need them. WCG excels at forming strategic partnerships to introduce and create access to new contraceptive methods around the world. For more information, visit www.wcgcares.org.
About Population Services International
Population Services International (PSI) is a leading global health organization working in reproductive health, HIV, malaria, child survival, non-communicable diseases and sanitation. Partnering with the public sector and harnessing the power of markets, PSI helps people in the developing world lead healthier lives and plan the families they desire. PSI manages social franchises that provide affordable health care products and services, as well as empowering communities and families through health education. PSI runs programs in 50 countries across the world and operates franchise networks in 30 countries in Asia, Africa and Latin America. For more information, visit www.psi.org.